Latest Capital Raising News

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

Aumega Metals has voluntarily suspended its ASX securities as it finalises a capital raising involving a significant new investor. The suspension is expected to last until the capital raising is completed and announced, or until trading resumes on 19 February.

Trek Metals has raised $15 million through a strongly supported share placement to fund a major drilling campaign at its promising Kuro manganese discovery in Western Australia’s Kimberley region.

Contact Energy has successfully completed a NZ$450 million placement as part of a NZ$525 million equity raise, supported by both existing and new international investors. The company now opens a NZ$75 million retail offer to eligible shareholders, marking a significant capital expansion.

29Metals has successfully completed the retail portion of its entitlement offer, raising $31 million and finalising a $150 million capital injection to support its growth ambitions.

Adavale Resources has secured adjacent exploration licences from Alkane Resources, boosting its Parkes Gold-Copper Project footprint and strengthening its position along a key gold corridor in New South Wales.

Judo Bank has reported a robust half-year result with profit before tax surging 53% year-on-year, driven by strong SME loan growth and improved operating efficiency. The bank reaffirms its FY26 guidance, signalling confidence in continued momentum.

TradeWindow has successfully closed its NZ$5.9 million Share Purchase Plan, with retail investors contributing around NZ$217,000. Shares will be allotted at NZ$0.25 each, matching the previous placement price.

BPH Energy has successfully raised $0.54 million by issuing over 542 million new listed options, allowing existing option holders to maintain their stake in the company’s future.

Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.

Qualitas Limited has delivered a standout first half of FY26, posting a 30% rise in normalised net profit before tax and record investment deployment, reinforcing its position in Australia’s alternative investment sector.